A report is presented of a patient who developed the Lupus syndrome while on treatment with hydrallazine. A significant anaemia was present which was fully investigated. The aetiology of the anaemia is discussed.
Get full access to this article
View all access options for this article.
References
1.
Alarcon-SegoviaDWakimKGWorthingtonJW. Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore)1967; 46:1–33.
2.
OrensteinAAYakulisVEipeJCosteaN, Immune haemolysis due to hydralazine (letter). Ann Intern Med1977; 86:450–451.
3.
WeinsteinJ. Hypocomplementaemia in hydrallazine-associated systemic lupus erythematosus. Am J Med1978; 65:553–556.
4.
StrandbergIBomanGHasslerL. Acetylator phenotype in patients with hydrallazine-induced lupoid syndrome. Acta Med Scand1976; 200:367–371.
5.
BatchelorJR. Hydrallazine-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility. Lancet1980; 8178:1107–1109.
